|
業務類別
|
Medical Devices |
|
業務概覽
|
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US. |
| 公司地址
| One Edwards Way, Irvine, CA, USA, 92614 |
| 電話號碼
| +1 949 250-2500 |
| 傳真號碼
| +1 949 250-2525 |
| 公司網頁
| https://www.edwards.com |
| 員工數量
| 16000 |
| Mr. Daniel J. Lippis |
Corporate Vice President, Transcatheter Aortic Valve Replacemen |
-- |
26/03/2026 |
| Mr. Wayne T. Markowitz |
General Manager and Senior Vice President, Surgical Structural Heart |
-- |
26/03/2026 |
| Ms. Annette Bruls |
Corporate Vice President, EMEACLA |
美元 726.59K |
26/03/2026 |
| Mr. Daveen Chopra |
Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies |
美元 671.04K |
26/03/2026 |
| Mr. Bernard J. Zovighian |
Director and Chief Executive Officer |
美元 1.19M |
26/03/2026 |
| Mr. Andrew M. Dahl |
Principal Accounting Officer, Senior Vice President and Corporate Controller |
-- |
25/02/2026 |
| Mr. Donald E. Bobo,Jr |
Corporate Vice President, Strategy and Corporate Development |
美元 759.78K |
26/03/2026 |
| Ms. Theodora Mistras |
Corporate Vice President and Chief Financial Officer |
-- |
04/05/2026 |
|
|
| Mr. Paul A. Laviolette |
Independent Director |
26/03/2026 |
| Mr. Nicholas J. Valeriani |
Chairman of the Board |
26/03/2026 |
| Ms. Ramona A. Sequeira |
Independent Director |
26/03/2026 |
| Mr. Bernard J. Zovighian |
Director and Chief Executive Officer |
26/03/2026 |
| Mr. Steven R. Loranger |
Independent Director |
26/03/2026 |
| Mr. Kieran T. Gallahue |
Independent Director |
26/03/2026 |
| Ms. Leslie C. Davis |
Independent Director |
26/03/2026 |
| Dr. David T. Feinberg, M.D.,PhD |
Independent Director |
26/03/2026 |
| Ms. Leslie Stone Heisz |
Independent Director |
26/03/2026 |
|
|
|
|
